Organic Acids
Sigma Aldrich Fine Chemicals Biosciences Glacial Acetic acid, 64-19-7, MFCD00036152, 500mL
Linear Formula CH3CO2H, Purity ≥99.7%, Molecular Weight 60.05, ACS reagent, Acetic acid is an organic carboxylic acid. It is a pungent smelling hygroscopic liquid. Glacial acetic acid is the anhydrous acetic acid. It forms dimers linked by hydrogen bonds in solution and gaseous commonly referred as phases. It is weakly acidic in nature.
Electron Microscopy Sciences Cacodylic Acid, Free Acid 100 GR
(Dimethylarsinic Acid)
CAS #75-60-5 (CH₃)₂AsO₂H F.W. 137.99
Assay: 99.5%
Electron Microscopy Sciences Acetic Acid 0.2% 500 ML
Prepared from acetic acid glacial with de-ionized water
Electron Microscopy Sciences Cacodylic Acid-Sodium Salt, 124-65-2, MFCD00149079, 100 g
Formula: C2H6AsNaO2.3H2O, MW: 214.02, 99.52%, Small white crystals, Names: Sodium dimethyl arsenate, TrihydrateSodium Cacodylate.
TARGETMOL CHEMICALS INC QUILSECONAZOLE FORMIC AC 5MG
Also available in 1 mg 10 mg 25 mg 50 mg 100 mg 500 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Quilseconazole Formic acid is a selective inhibitor of fungal Cyp51 with potent activities against Cryptococcus neoformans and Cryptococcus gattii.
Medchemexpress LLC Formic acid ammonium salt | 540-69-2 | MFCD00013103 | 98.5% | 63.06 | CH5NO2 | 1mL
Formic acid ammonium salt is an endogenous metabolite
Medchemexpress LLC Zelavespib formic | 97.4% | 558.39 | 25 MG
Zelavespib formic (PU-H71 formic) is a potent Hsp90 inhibitor with an IC50 value of 51 nM for Hsp90 in MDA-MB-468 cells. It is intended for research use only.
- Potent Hsp90 inhibitor
- Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO
- Available in various solid forms (5 mg, 10 mg, 25 mg, 50 mg, 100 mg)
- Also available in solution form (10 mM * 1 mL in DMSO)
- Cited in 12 publications
- Related to various compound screening libraries and small molecules
- Clinical trials listed for Metastatic Breast Cancer, Accelerated Phase MPN, Blast Phase MPN, Metastatic Solid Tumor, Lymphoma, Myeloproliferative Neoplasms (MPN), Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)
Medchemexpress LLC SJ1008030 formic | 2863634-96-0 | 97.7% | 919.96 | 50 MG
SJ1008030 formic is a JAK2 PROTAC that selectively degrades JAK2, making it suitable for leukemia research. It inhibits MHH-CALL-4 cell growth with an IC50 of 5.4 nM.
- Selectively degrades JAK2
- Inhibits MHH-CALL-4 cell growth
- Useful for leukemia research
- Degrades JAKs, GSPT1, and IKZF1 in a dose-dependent manner
- Inhibits JAK-STAT signaling pathway